Martin-Sanchez et al., 2021 - Google Patents
Immunological biomarkers of fatal COVID-19: a study of 868 patientsMartin-Sanchez et al., 2021
View HTML- Document ID
- 7336337247708921516
- Author
- Martin-Sanchez E
- Garces J
- Maia C
- Inoges S
- Lopez-Diaz de Cerio A
- Carmona-Torre F
- Marin-Oto M
- Alegre F
- Molano E
- Fernandez-Alonso M
- Perez C
- Botta C
- Zabaleta A
- Alcaide A
- Landecho M
- Rua M
- Perez-Warnisher T
- Blanco L
- Sarvide S
- Vilas-Zornoza A
- Alignani D
- Moreno C
- Pineda I
- Sogbe M
- Argemi J
- Paiva B
- Yuste J
- Publication year
- Publication venue
- Frontiers in Immunology
External Links
Snippet
Information on the immunopathobiology of coronavirus disease 2019 (COVID-19) is rapidly increasing; however, there remains a need to identify immune features predictive of fatal outcome. This large-scale study characterized immune responses to severe acute …
- 200000000015 coronavirus disease 2019 0 title abstract description 161
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chua et al. | COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis | |
| Saris et al. | Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19 | |
| Li et al. | Whole‐transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID‐19 patients | |
| Martin-Sanchez et al. | Immunological biomarkers of fatal COVID-19: a study of 868 patients | |
| Wei et al. | Hypomethylation of the IL17RC promoter associates with age-related macular degeneration | |
| Fraser et al. | Multi-modal characterization of monocytes in idiopathic pulmonary fibrosis reveals a primed type I interferon immune phenotype | |
| Chan Zuckerberg Initiative Single-Cell COVID-19 Consortia et al. | Single cell profiling of COVID-19 patients: an international data resource from multiple tissues | |
| Huang et al. | Up-regulation of circRNA-0003528 promotes mycobacterium tuberculosis associated macrophage polarization via down-regulating miR-224-5p, miR-324-5p and miR-488-5p and up-regulating CTLA4 | |
| Shaath et al. | Identification of PBMC-based molecular signature associational with COVID-19 disease severity | |
| Pekayvaz et al. | Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection | |
| Sheerin et al. | Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection | |
| Leite et al. | Combined transcriptome and proteome leukocyte’s profiling reveals up-regulated module of genes/proteins related to low density neutrophils and impaired transcription and translation processes in clinical sepsis | |
| Lorente-Pozo et al. | DNA methylation analysis to unravel altered genetic pathways underlying early onset and late onset neonatal sepsis. a pilot study | |
| Sfikakis et al. | Blood transcriptomes of anti-SARS-CoV-2 antibody-positive healthy individuals who experienced asymptomatic versus clinical infection | |
| Wang et al. | LOC152742 as a biomarker in the diagnosis of pulmonary tuberculosis infection | |
| Verrou et al. | Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome | |
| Liu et al. | Multi-omics integration reveals only minor long-term molecular and functional sequelae in immune cells of individuals recovered from COVID-19 | |
| Xu et al. | Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls | |
| Lindestam Arlehamn et al. | T-cell deficiency and hyperinflammatory monocyte responses associate with Mycobacterium avium complex lung disease | |
| Lavalett et al. | Human alveolar and splenic macrophage populations display a distinct transcriptomic response to infection with Mycobacterium tuberculosis | |
| Xiong et al. | Cytotoxic CD161− CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus | |
| Li et al. | Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents | |
| Sun et al. | Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses | |
| An et al. | Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms | |
| Bingham et al. | High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis |